These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 28984591)
1. Curcumin Inhibits Tau Aggregation and Disintegrates Preformed Tau Filaments in vitro. Rane JS; Bhaumik P; Panda D J Alzheimers Dis; 2017; 60(3):999-1014. PubMed ID: 28984591 [TBL] [Abstract][Full Text] [Related]
2. C1 Inhibits Liquid-Liquid Phase Separation and Oligomerization of Tau and Protects Neuroblastoma Cells against Toxic Tau Oligomers. Pradhan A; Mishra S; Surolia A; Panda D ACS Chem Neurosci; 2021 Jun; 12(11):1989-2002. PubMed ID: 34008959 [TBL] [Abstract][Full Text] [Related]
3. Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation. Sonawane SK; Uversky VN; Chinnathambi S Cell Commun Signal; 2021 Feb; 19(1):16. PubMed ID: 33579328 [TBL] [Abstract][Full Text] [Related]
4. Aggregation analysis of the microtubule binding domain in tau protein by spectroscopic methods. Yao TM; Tomoo K; Ishida T; Hasegawa H; Sasaki M; Taniguchi T J Biochem; 2003 Jul; 134(1):91-9. PubMed ID: 12944375 [TBL] [Abstract][Full Text] [Related]
5. Resonance Raman spectroscopic measurements delineate the structural changes that occur during tau fibril formation. Ramachandran G; Milán-Garcés EA; Udgaonkar JB; Puranik M Biochemistry; 2014 Oct; 53(41):6550-65. PubMed ID: 25284680 [TBL] [Abstract][Full Text] [Related]
6. Effective suppression of the modified PHF6 peptide/1N4R Tau amyloid aggregation by intact curcumin, not its degradation products: Another evidence for the pigment as preventive/therapeutic "functional food". Bijari N; Balalaie S; Akbari V; Golmohammadi F; Moradi S; Adibi H; Khodarahmi R Int J Biol Macromol; 2018 Dec; 120(Pt A):1009-1022. PubMed ID: 30172816 [TBL] [Abstract][Full Text] [Related]
7. The Polyphenol Altenusin Inhibits in Vitro Fibrillization of Tau and Reduces Induced Tau Pathology in Primary Neurons. Chua SW; Cornejo A; van Eersel J; Stevens CH; Vaca I; Cueto M; Kassiou M; Gladbach A; Macmillan A; Lewis L; Whan R; Ittner LM ACS Chem Neurosci; 2017 Apr; 8(4):743-751. PubMed ID: 28067492 [TBL] [Abstract][Full Text] [Related]
8. Cannabidiol Inhibits Tau Aggregation In Vitro. Alali S; Riazi G; Ashrafi-Kooshk MR; Meknatkhah S; Ahmadian S; Hooshyari Ardakani M; Hosseinkhani B Cells; 2021 Dec; 10(12):. PubMed ID: 34944028 [TBL] [Abstract][Full Text] [Related]
9. Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer's disease. Cornejo A; Jiménez JM; Caballero L; Melo F; Maccioni RB J Alzheimers Dis; 2011; 27(1):143-53. PubMed ID: 21785188 [TBL] [Abstract][Full Text] [Related]
10. Effects of tau domain-specific antibodies and intravenous immunoglobulin on tau aggregation and aggregate degradation. Esteves-Villanueva JO; Trzeciakiewicz H; Loeffler DA; Martić S Biochemistry; 2015 Jan; 54(2):293-302. PubMed ID: 25545358 [TBL] [Abstract][Full Text] [Related]
11. An acetylation mimicking mutation, K274Q, in tau imparts neurotoxicity by enhancing tau aggregation and inhibiting tubulin polymerization. Rane JS; Kumari A; Panda D Biochem J; 2019 May; 476(10):1401-1417. PubMed ID: 31036717 [TBL] [Abstract][Full Text] [Related]
12. Shikonin impedes phase separation and aggregation of tau and protects SH-SY5Y cells from the toxic effects of tau oligomers. Venkatramani A; Mukherjee S; Kumari A; Panda D Int J Biol Macromol; 2022 Apr; 204():19-33. PubMed ID: 35120943 [TBL] [Abstract][Full Text] [Related]
13. Granular tau oligomers as intermediates of tau filaments. Maeda S; Sahara N; Saito Y; Murayama M; Yoshiike Y; Kim H; Miyasaka T; Murayama S; Ikai A; Takashima A Biochemistry; 2007 Mar; 46(12):3856-61. PubMed ID: 17338548 [TBL] [Abstract][Full Text] [Related]
14. Assays for the Screening and Characterization of Tau Aggregation Inhibitors. Rickard JE; Horsley D; Wischik CM; Harrington CR Methods Mol Biol; 2017; 1523():129-140. PubMed ID: 27975248 [TBL] [Abstract][Full Text] [Related]
15. Fourier Transform Infrared (FTIR) Spectroscopy, Ultraviolet Resonance Raman (UVRR) Spectroscopy, and Atomic Force Microscopy (AFM) for Study of the Kinetics of Formation and Structural Characterization of Tau Fibrils. Ramachandran G Methods Mol Biol; 2017; 1523():113-128. PubMed ID: 27975247 [TBL] [Abstract][Full Text] [Related]
16. Analyzing Tau Aggregation with Electron Microscopy. Huseby CJ; Kuret J Methods Mol Biol; 2016; 1345():101-12. PubMed ID: 26453208 [TBL] [Abstract][Full Text] [Related]
17. Molecular hairpin: a possible model for inhibition of tau aggregation by tannic acid. Yao J; Gao X; Sun W; Yao T; Shi S; Ji L Biochemistry; 2013 Mar; 52(11):1893-902. PubMed ID: 23442089 [TBL] [Abstract][Full Text] [Related]
18. Protein anatomy: C-tail region of human tau protein as a crucial structural element in Alzheimer's paired helical filament formation in vitro. Yanagawa H; Chung SH; Ogawa Y; Sato K; Shibata-Seki T; Masai J; Ishiguro K Biochemistry; 1998 Feb; 37(7):1979-88. PubMed ID: 9485325 [TBL] [Abstract][Full Text] [Related]
19. Pseudophosphorylation of tau protein directly modulates its aggregation kinetics. Chang E; Kim S; Schafer KN; Kuret J Biochim Biophys Acta; 2011 Feb; 1814(2):388-95. PubMed ID: 20974297 [TBL] [Abstract][Full Text] [Related]
20. Molecular "light switch" [Ru(phen)2dppzidzo](2+) monitoring the aggregation of tau. Gao X; Wang L; Huang HL; Wang LL; Yao JL; Shi S; Yao TM Analyst; 2015 Nov; 140(22):7513-7. PubMed ID: 26460552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]